A New Conjugate Meningococcal Vaccine (Menveo)
The FDA has approved Menveo (Novartis), a new quadrivalent conjugated polysaccharide vaccine, for
protection against disease caused by Neisseria meningitidis in people 11-55 years old....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: A New Conjugate Meningococcal Vaccine (Menveo)
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1343
Article Code: 1343b
Date: July 26, 2010
Volume: 52
Pages: 59-60
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1343
Article Code: 1343b
Date: July 26, 2010
Volume: 52
Pages: 59-60
Add this downloadable, electronic article to your cart (U.S. English version only) Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article.